You are here » Home » Companies » Company Overview » Scandent Imaging Ltd

Scandent Imaging Ltd.

BSE: 516110 Sector: Health care
NSE: N.A. ISIN Code: INE146N01016
BSE 00:00 | 03 Jul 12.40 0.59
(5.00%)
OPEN

12.40

HIGH

12.40

LOW

12.25

NSE 05:30 | 01 Jan Scandent Imaging Ltd
OPEN 12.40
PREVIOUS CLOSE 11.81
VOLUME 38
52-Week high 14.33
52-Week low 6.73
P/E 29.52
Mkt Cap.(Rs cr) 40
Buy Price 12.40
Buy Qty 1.00
Sell Price 12.40
Sell Qty 2.00
OPEN 12.40
CLOSE 11.81
VOLUME 38
52-Week high 14.33
52-Week low 6.73
P/E 29.52
Mkt Cap.(Rs cr) 40
Buy Price 12.40
Buy Qty 1.00
Sell Price 12.40
Sell Qty 2.00

Scandent Imaging Ltd. (SCANDENTIMAGING) - Company History

Established in 1982 as a partnership firm, Pharma Offset became a public limited company in Sep.'94. It was promoted by Rashmikant C Doshi and Uday M Raval. The company is engaged in manufacturing, processing, printing and packaging products. The company's product profile consists of cartons, pharmaceutical sales promotion literature, primary packaging materials, etc. The company undertook an expansion-cum-modernisation programme in 1994-95. It came out with a public issue in Jan.'95 to part-finance the project. Pharma Offset supplies its products to reputed pharmaceutical companies like Lyka Labs, Dolphin Laboratories and to multi-nationals like Parke-Davis, Sandoz, Merind, Fulford (India), etc. The company has entered into a firm tie-up with Lyka Labs and Dolphin Laboratories for an offtake of upto 60% of the expanded capacity. In 1998-99, the company commenced an additional activity of trading in chemicals and bulk drugs. During the year 1999-2000, the company has changed its name to Pharma Com (India) Ltd.